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Background: Less invasive surfactant administration (LISA) to spontaneously breathing preterm infants has been
reported to reduce the duration of mechanical ventilation and the incidence of bronchopulmonary dysplasia (BPD)
in previous study. The objective of this study was to explore the feasibility and potential benefits of LISA in early
preterm infants on nasal continuous positive airway pressure (nCPAP) compared to conventional endotracheal
instillation.
Methods: All infants with respiratory distress born at 28–32 weeks’ gestational age from January 2012 to December
2012 (n=90), who were eligible for exogenous pulmonary surfactant (PS) therapy were randomized to receive PS by
intubation with an endotracheal tube (Intubation group, n=43), or by intubation using a catheter while on nCPAP
(LISA group, n=47). Respiratory indices were recorded every 30 seconds during PS administration, and every 1 hour
thereafter for the first day. The rate of mechanical ventilation (MV) in the first 72 hours, mean duration of both MV
and nCPAP, mean duration of oxygen requirement and neonatal outcomes were recorded.
Results: PS was successfully administered in 43 (100%) out of 43 babies using the conventional approach and in
46 (97%) out of 47 babies using LISA. The duration of both MV and nCPAP was significantly shorter in LISA group,
when compared with intubation group. However, there were no significant differences in both the rate of MV in
the first 72 hours and mean duration of oxygen requirement. There were also no differences in the mortality or in
the incidence of bronchopulmonary dysplasia, intraventricular hemorrhage, retinopathy of prematurity and
necrotizing enterocolitis, or in the duration of respiratory support.
Conclusions: LISA in spontaneously breathing infants on nCPAP is an alternative therapy for PS delivery, avoiding
intubation with an endotracheal tube. The method is feasible and potentially effective, and deserves further clinical
trials.
Trial registration: Current Controlled Trials ChiCTR-ICR-15006001. Registered 20 February 2015.
Keywords: Respiratory distress syndrome, Less invasive surfactant administrationBackground
Large randomized controlled trials in very preterm ba-
bies show that initial nasal continuous positive airway
pressure (nCPAP) therapy results in less mechanical
ventilation (MV) and a trend towards lower risks for
bronchopulmonary dysplasia (BPD) [1,2]. On the other* Correspondence: tinybaby@sina.com
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unless otherwise stated.hand, exogenous pulmonary surfactant (PS) therapy has
been shown to substantially improve outcomes of pre-
term infants with respiratory distress syndrome [3,4].
Recognizing the merits of surfactant, especially when
given early, some clinicians choose to intubate infants
on CPAP solely for the purpose of giving PS, followed by
immediate extubation. However, approximately 10% of
those intubated solely for surfactant administration
could not be extubated within 1 h [5]. In addition, intub-
ation of the trachea with an endotracheal tube is an in-
vasive procedure and may not be without risk.is is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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sued. In 1992, Verder firstly described the use of a thin
diameter catheter to apply surfactant to premature in-
fants with emerging RDS on CPAP [6]. However, the ob-
servation study had not been paid much attention, until
Kribs and colleagues used a similar method, which was
called less invasive surfactant administration again in
clinical observations (LISA), in Cologne [7]. The tech-
nique rapidly spread in Germany. Although no improved
effects on long-term outcome have so far been demon-
strated, these methods have shown promise in terms of
achieving a clinical response without passing an endo-
tracheal tube or using mechanical ventilation [8,9]. In
previous studies, sedation and/or analgesia and/or atro-
pine, to reduce secretions, may be given prior to the
procedure. However, medication may interfere both with
cardiovascular function (blood pressure) and respiratory
effort.
The aim of our study was to assess the efficacy and
the feasibility of LISA technique without medication




The study was conducted in the Neonatal Intensive Care
Units of the Women’s Hospital, Zhejiang University,
School of Medicine from January 2012 to December
2012. The Ethics Committee of the Women’s Hospital,
Zhejiang University, School of Medicine approved the
study. A written informed consent for participation in
the study was obtained from the parent of infants.
Inclusion criteria were: (1) infants born at 28 to
32 weeks gestational age. (2) Infants with RDS and need
PS administration with 2 hr after birth. Exclusion criteria
were: (1) infants who had been previously intubated and
(2) infants with a congenital anomaly affecting respira-
tory function.
The diagnosis of respiratory distress syndrome (RDS)
was based on the occurrence of classic signs of respira-
tory distress such as the need for oxygen, tachypnea,
intercostal muscle retractions, grunting, and the exclu-
sion of other causes of respiratory failure. The diagnosis
was confirmed radiologically by reduced lung volumes, a
reticulogranular pattern of lung consolidation, and air
bronchograms [10]. Nasal continue positive airway pres-
sure (nCPAP) was the initial means of respiratory sup-
port. Distending pressure ranged from 5 to 8 cm H2O,
titrated according to oxygen requirement and work of
breathing. Infants with signs of RDS, who were received
nCPAP treatment and required nCPAP pressures ≧7 cm
H2O and FiO2 ≧0.3 (28
+0-29+6 weeks gestation) or ≧0.35
(30+0–32+6 weeks) to maintain SpO2 levels between 85%
and 95%, were randomized to receive PS treatment(Curosurf, Chiesi Farmaceutici, Parma, Italy) at a dose of
200 mg/kg either by LISA procedure or conventional in-
tubation. Infants were intubated, if FiO2 was ≧0.5, or if
there was respiratory acidosis (pH <7.2) or significant
apnea.
Surfactant administration
During process of surfactant administration, the concen-
tration of oxygen (FiO2) was adjusted using a blender to
maintain oxygen saturation within the range of 85–95%.
LISA procedure
A 16 gauge, 130 mm vascular catheter (16G Angiocath,
BD, Sandy, Utah, USA) was marked to indicate desired
depth of insertion (28–29 weeks: 1.5 cm, 30–32 weeks:
2 cm). Direct laryngoscopy was performed, and the
vascular catheter was inserted beyond the vocal cords to
the required depth, and held in position at lips. If
catheterization of the trachea was not possible within
20–30 s, the procedure was discontinued and attempted
again once the baby was stable. Once the catheter was
correctly positioned, surfactant was given at a standard
dose as 5 boluses or more over 3-5 min. The tracheal
catheter was immediately withdrawn. Infants were con-
tinued on nCPAP throughout the procedure. Positive
pressure inflations were given by mask, if the infant de-
veloped apnoea or bradycardia.
Conventional intubation procedure
Surfactant instillation via endotracheal tube (ET) was
performed with some brief mechanical ventilations, a
standard dose of surfactant was always divided into 2 or
3 boluses. The endotracheal tube was withdrawn as
soon as clinically possible after PS instillation, and
the baby switched to nCPAP. The whole procedure
took about 3 min and occurred without continuous dis-
tending pressure.
Management after surfactant administration
After procedure, infants were stabilized on nCPAP. If
FiO2 was >0.6, or if there was sustained respiratory
acidos (pH <7.2) or repeated apnea, infants were intu-
bated and receive MV. A further dose of surfactant
(100 mg/kg) was given after intubation if clinically
indicated. Care throughout hospitalization was as per
routine for all infants, including monitoring for, and
treatment of, patent ductus arteriosus (PDA), and screen-
ing for intraventricular haemorrhage (IVH) and retin-
opathy of prematurity (ROP) according to standard
schedules of our center.
Data collection
For each eligible infant, details during the PS instillation,
including pulse oximetry saturation, heart rate and FiO2,
Figure 1 Trial profile.






Gestation age (weeks), mean (SD) 29.1 (1.5) 29.3 (1.6) 0.54
Birth weight (grams), mean (SD) 1034 (221) 1087 (198) 0.24
Male gender, n (%) 28 (59.6) 26 (60.4) 0.93
Singleton, n (%) 21 (44.7) 19 (44.2) 0.96
Complete antenatal corticosteroids,
n (%)
42 (89.4) 40 (93.0) 0.54
Cesarean section, n (%) 35 (74.5) 33 (76.7) 0.80
1 Min Apgar score 6.4 (0.8) 6.3 (1.2) 0.64
5 Min Apgar score 8.7 (0.6) 8.8 (0.7) 0.47
FiO2 prior to surfactant administration 0.43 (0.05) 0.43 (0.08) 1.0
PEEP prior to surfactant administration 6.5 (0.8) 6.4 (1.1) 0.62
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3 min, along with pO2 and pCO2 values from blood gas
samples before, and 1 h after PS administration. Changes
in nCPAP pressure were recorded every 30 min in the
first 4 hr, and at 12 and 24 h of life. Demographical data
and early neonatal outcomes were recorded for all in-
fants including need for intubation and mechanical ven-
tilation in the first 72 h (and thereafter), further PS
therapy. Mortality incidence of bronchopulmonary dys-
plasia (BPD) [11], PDA requiring medical and/or surgical
therapy, intraventricular hemorrhage (IVH) grades III
and IV [12], retinopathy of prematurity (ROP) greater
than stage 2 [13] and necrotizing enterocolitis (NEC) on
Bell stage II or III [14] were noted. The duration of
respiratory support, including respiratory assistance
(mechanical ventilation and/or nCPAP), oxygen therapy
and intensive care admission were also recorded.
Statistical analysis
We performed a power calculation analysis to determine
the number of the study population. Since compared
with the previous study [7,15], the gestational ages of in-
fants were relatively older, hence to decrease the rate of
intubation by 50%, about 60 infants in each group were
needed to be recruited. Data were expressed as propor-
tion, mean ± standard deviation (m ± SD) or median
(interquartile range). Proportions were compared by
Chi-square analysis. Continuous variables were com-
pared by Student’s t test or Mann–Whitney U test
according to their distribution. A p value <0.05 was con-
sidered statistically significant. Statistical analysis was
carried out using the SPSS software, version 19.0 for
Windows (SPSS, Chicago, IL, USA).
Results
During the study period, 204 infants with 28–32 gesta-
tional age, were born in our hospital. 141 infants weretreated with nCPAP immediately after birth and assessed
possibly for surfactant treatment; a total of 90 infants
comprised the study group and were randomized into
either LISA group or conventional intubation group, 47
infants in LISA group and 43 infants in conventional
group were eligible for the statistical analysis (Figure 1).
Demographic and clinical characteristics of the in-
fants receiving surfactant by LISA were generally well
matched with those managed by conventional intubation
(Table 1).
The LISA technique and conventional surfactant
administration were performed by 2 neonatal consul-
tants and 3 neonatal fellows, with successful administration
of surfactant in every case. A second or more
catheterization attempts were required in 10.6% of
infants who received PS by LISA, and a second or more
intubation attempts were required in 14.0% of control
infants (5 out of 47 vs. 6 out of 43, p=0.63).
A decrease in PEEP and FiO2 was noted after LISA
and conventional PS administration, sustained at least
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were noted in conventional intubation group. During the
whole procedure of PS administration, there was less
fluctuation of FiO2 and oxygen saturation in infant re-
ceiving LISA. The final effects of providing PS using the
two methods were similar (Figure 2). However, cases of
surfactant reflux were more frequent in the LISA group
(17 out of 47 vs. 5 out of 43, p=0.01).
Postnatal respiratory assistance outcomes (except the
duration of both mechanical ventilation and nCPAP),
morbidities (BPD, ROP, NEC and PDA), and mortality
during the first 28 days of age were similar in the two
groups (Table 2).
Discussion
RDS is a common condition affecting very preterm in-
fants, who often require surfactant replacement therapy.
More and more preterm infants with respiratory distress
are now treated with nCPAP soon after birth. The issue
that intubation is solely required for the purpose of sur-
factant administration has risen. The operation of LISA
aims at reducing the failure rate of nCPAP and minimiz-
ing intubation injury. However, LISA is not the “one size
fits all” solution for surfactant therapy in premature in-
fants [16]. The optimal gestational age and risk factors
for failure of LISA are still not determined [17,18].
In this pilot randomized controlled trial, we show that
LISA can be successfully applied to 28–32 gestational
age infants with RDS who are receiving nCPAP, with no
significant procedural complications. Moreover, the
technique of LISA was relatively easy to learn: Given theFigure 2 Respiratory indices before and after surfactant administratio
surfactant administration.initial lack of experience with LISA, there were a rela-
tively low proportion of cases requiring a second
catheterization attempts (2 out of the first 10 infants).
We speculate that a narrow bore designed catheter, in-
stead of conventional endotracheal tube was the main
reason for the ease, because an external diameter about
1 mm of the catheter could be passed down and easily
through the vocal cords. In our experience, the most dif-
ficulty of the method was how to perform direct laryn-
goscopy and expose the vocal cords on the infant with
RDS on NCPAP. In the pilot trial, one baby was intoler-
ant to LISA: the infant became and remained apneic
while the catheter was intratracheal. This complication
is rarely described in the literature. Two issues need to
be discussed. One is the issue of sedation. The rate of
sedation before the operation of LISA varied from about
0 in the study of Kanmaz, H. G et al.[19] to 26% in
AMV study [15] or more in other study [20]. Although
there was no consensus that sedation should be use be-
fore the operation of LISA, use of sedation may be a
good choice. Further study of LISA may be focused on
the issue of premedication. The other is the result of ex-
cessive individual sensitivity to airway manipulation,
which was probably the cause of apnea in our infants.
Thus, we infer that LISA may not be suitable for all pre-
mature infants.
In our study, we explored not only the respiratory in-
dices pre-and post-surfactant administration, but also
the change of FiO2 and SpO2 every 30 seconds during
the procedure of surfactant administration by LISA,
which were seldom reported in the previous papersn-all infant, zero indicates the start of pulmonary







Time of first surfactant dose (min) 65 (20.7) 63 (25.3) 0.68
Two or more dose surfactant 8 (17.0) 5 (11.4) 0.44
pneumothorax 4 (8.9) 3 (7.0) 0.79
Supplemental O2 at age of 28 days 12 (25.5) 11 (25.6) 0.81
BPD 6 (12.8) 6 (14.0) 0.87
Mild 5 (10.6) 5 (11.6) 0.85
Moderate or severe, n (%) 1 (2.1) 1 (2.3) 0.51
PDA treat with medical therapy 28 (59.6) 26 (60.5) 0.93
PDA treat with surgery 1 (2.1) 0 (0) 0.34
IVH grades I or II 23 (48.9) 21 (47.7) 0.91
IVH grades III or IV 1 (2.1) 0 (0) 0.34
PVL 1 (2.1) 1 (2.3) 0.51
ROP > stage 2 0 0 ns
Respiratory support
Mechanical ventilation during the
first 72 hr, n (%)*
8 (17.0) 10 (23.3) 0.44
Mechanical ventilation days 6.7 (3.5) 7.4 (4.3) 0.40
nCPAP, n (%)# 47 (100) 43 (100) ns
nCPAP days 10.9 (7.8) 12.3 (8.4) 0.41
Both MV and nCPAP days 13.2 (6.7) 15.9 (5.1) 0.03
Oxygen, n (%)* 38 (80.8) 34 (79.1) 0.83
Oxygen days 20.7 (5.2) 22.3 (6.9) 0.22
In hospital days 68.5 (17.3) 70.1 (22.5) 0.70
Died during the first 28 days 1 (2.1) 0 (0) 0.34
#need NCPAP during the hospitalization.
*need oxygen by mask or nasal tube during the hospitalization.
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physiological benefit, with a rapid and sustained reduc-
tion in FiO2 after surfactant administration by both
LISA and conventional management. Although, it took
longer (mean 3.2 min) to complete the whole LISA pro-
cedure, and more surfactant reflux was observed during
LISA procedure.
Our results on the clinical benefits of LISA was
slightly different from previous studies of minimally in-
vasive PS instillation [19,23,24,27]. In the pilot study, we
only found that LISA had benefit in reducing the dur-
ation of both ventilation and nCPAP, instead of reducing
the rate of ventilation during the first 72 hours. Consist-
ent with previous studies [15,20,23], we found that LISA
had no benefit on reducing incidence of BPD. We specu-
late that this discrepancy could be explained by the
difference in our patient demographics: infants who re-
ceived PS in our study were an average of 29 weeks GA
in our study. Our future studies will focus on the infantswith less gestational age (24–28 weeks), who are more
likely to receive mechanical ventilation and require oxy-
gen for a longer time.
Fluctuations in oxygen saturation have been associated
with certain neonatal diseases, including BPD, IVH and
ROP [28-30]. We found conventional PS administration,
especially with bag-mask ventilation, when compared
with LISA was more likely to result in oxygen satura-
tions greater than 95%, and infants would experience
brief periods of desaturation after extubation (lasting
about 3-5 min). We infer that we should pay attention
to regulate tidal volumes and oxygen concentration and
closely monitor the oxygen saturation during the whole
procedure of PS administration.
Our study was an open-label, randomized, controlled
pilot with a sample of about 90 infants. Since the opti-
mal oxygen saturation for premature infants was chan-
ged to 90-95% in our NICU in 2014, we had to restrict
our analysis to the data that had been gathered in 2013,
with the pre-specified saturation ranges of 85-95%. This
led to us not achieving the requisite sample size. Our re-
sults warrant further study. A large multicenter trial
would be required to confirm that LISA reduces the dur-
ation of mechanical ventilation and oxygen therapy.
Moreover, such studies would give us more information
about the practicalities and complications of LISA.Conclusion
The LISA technique in spontaneously breathing infants
on nCPAP is feasible, may prevent intubation with an
endotracheal tube in certain premature babies. Further
clinical trials are required to confirm the optimal strat-
egy and the patient population in which the effect would
be greatest.
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